# Arteriocyte Medical Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arteriocyte-medical-systems

- Industry: Medical Devices & Equipment
- Headquarters: Hopkinton, US
- Total disclosed funding: $10M
- Latest round: Series A (Oct 25, 2007)
- Investors on record: 1

## About

Founded in 2007 and based in Massachusetts, US, Arteriocyte Medical Systems, Inc. operates as a manufacturer of medical devices for surgical applications. The firm also develops an autologous platelet separator. Based in the United States, Arteriocyte Medical Systems, Inc. operates as a B2B medical device developer. The company provides innovative medical products for cardiac surgeries, orthopedic procedures, and vascular surgeries. Based in Massachusetts, United States and founded in 2007, Arteriocyte Medical Systems, Inc. provides advanced medical devices and biologic solutions for the healthcare industry. The company was established through a partnership between Arteriocyte, Inc. and DW Healthcare Partners to develop and market innovative products aimed at improving patient recovery and addressing unmet needs in cardiac, orthopedic, and vascular surgeries. Over the years, Arteriocyte Medical Systems has focused on delivering cutting-edge technologies that enhance healing and surgical outcomes for patients worldwide. In October 2016, Isto Holdings., a portfolio company of Thompson Street Capital Partners, acquired Arteriocyte Medical Systems, Inc., a portfolio company of DW Healthcare Partners. As a part of the transaction, ISTO Technologies’ Commercial Business will be rebranded to ISTO Biologics. Following the transaction ISTO Technologies and Arteriocyte Medical Systems will operate under the name of ISTO Biologics. The company works with healthcare providers, surgeons, and hospitals to provide innovative medical solutions that enhance patient recovery. The company develops and markets advanced medical devices and biologic products designed for cardiac surgery, orthopedic procedures, and vascular interventions, addressing critical unmet needs and improving surgical outcomes.

## Funding rounds

- Series A, Oct 25, 2007, $10M — DW Healthcare Partners

## Investors

- DW Healthcare Partners (https://capitalatlas.ai/funds/dw-healthcare-partners) — Series A